Security key
00430K865
Grace Therapeutics, Inc. - Common Stock (ACST)
CUSIP: 00430K865
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,265,432
- Total 13F value
- $4,337,046
- Share change
- +694,155
- SEC-reported price per share
- $3.42
- Number of holders
- 10
- Value change
- +$2,382,665
- Number of buys
- 4
- Number of sells
- 4
- Shares outstanding
- 16,612,245
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
10
Top holders
10
ACST full security history
Ownership snapshot
Full 13F holder table
Grace Therapeutics, Inc. SEC filings
Grace Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ACST - Grace Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
9/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 3%
6 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BANK OF AMERICA CORP /DE/ leads the comparable SEC ownership view at 3%.
9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Comparable ownership
Top 5
BANK OF AMERICA CORP /DE/
3%
ADAR1 Capital Management, LLC
0.21%
ROYAL BANK OF CANADA
0.19%
UBS Group AG
0.03%
NATIONAL BANK OF CANADA /FI/
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
3%
|
$1,429,677
494,698 shares
|
— | 31 Dec 2023 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.21%
|
$99,797
34,532 shares
|
— | 31 Dec 2023 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.19%
|
$92,000
31,584 shares
|
— | 31 Dec 2023 |
| UBS Group AG |
13F
Company
|
0.03%
|
$16,190
5,602 shares
|
— | 31 Dec 2023 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
0.02%
|
$7,970
2,901 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
0.01%
|
$5,439
1,882 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
1,265,432
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q1 2024 holders
10
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|